靜脈輸液袋市場規模、佔有率和成長分析（按容量、按最終用戶、按應用、按材料、按地區）：行業預測（2025-2032）

2023 年，全球靜脈 (IV) 輸液袋市場規模為 34 億美元，從 2024 年的 36.4 億美元成長到 2032 年的 63 億美元，預計 2017 年的複合年成長率為 2023 年。

由於減少醫院感染和交叉污染的技術創新以及一次性輸液袋的日益普及，醫用輸液袋市場正在經歷顯著成長。這些多功能袋子採用內袋和外塑膠塗層設計，可確保安全儲存血液樣本、藥物和輸液，並增強滅菌過程。這些袋子在液體治療、輸血和維持電解質平衡方面發揮重要作用，這對患者的健康至關重要。此外，擴大採用不含 PVC 和非乳膠的袋子，凸顯了該行業正在轉向更安全的替代品。由於醫療機構優先考慮感染控制，同時努力降低成本，預計未來幾年對這些先進輸液袋的需求將大幅增加。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管分析

全球靜脈輸液袋市場規模及複合年成長率：依產能分類（2025-2032）

• 市場概況
• 250毫升以下
• 250～500ml
• 500ml

全球靜脈輸液袋市場規模和複合年成長率：按最終用戶分類（2025-2032）

• 市場概況
• 醫院/診所
• 門診手術中心
• 居家醫療

全球靜脈輸液袋市場規模及複合年成長率：依應用分類（2025-2032）

• 市場概況
• 水合作用
• 用藥管理
• 輸血

全球靜脈輸液袋市場規模及複合年成長率：依材料分類（2025-2032）

• 市場概況
• PVC
• 非PVC

全球靜脈輸液袋市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• 百特國際公司（美國）
• B.Braun Melsungen AG（德國）
• 費森尤斯卡比股份公司（德國）
• ICU 醫療公司（美國）
• JW Life Science Corp.（韓國）
• 輝瑞公司（美國）
• 格里福爾斯，SA（西班牙）
• Amcor plc（瑞士）
• Technoflex（法國）
• Sippex（德國）（MEDIPPEX Co.）
• 波利辛有限公司（德國）
• 大塚製藥股份有限公司（日本）
• 尼普羅株式會社（日本）
• West Pharmaceutical Services, Inc.（美國）
• 史密斯醫療（英國）
• Haemotronic SpA（義大利）
• MedicoPack A/S（丹麥）
• 科騰公司（美國）
• PolyCine 有限公司（德國）
• Fosmo Med（中國）

結論和建議

Global Intravenous IV Fluid Bags Market size was valued at USD 3.4 billion in 2023 and is poised to grow from USD 3.64 billion in 2024 to USD 6.3 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The medical fluid bag market is witnessing significant growth, driven by innovations and a rising preference for disposable IV fluid bags to mitigate hospital-acquired infections and cross-contamination. Designed with an interior pouch and outer plastic coating, these versatile bags ensure the safe storage of blood samples, medications, and fluids, thereby enhancing sterilization processes. They play a critical role in fluid replacement therapy, blood transfusions, and maintaining electrolyte balance, which is vital for patient health. Moreover, the increasing adoption of PVC-free and non-latex bags highlights the industry's shift towards safer alternatives. As healthcare facilities prioritize infection control while striving to reduce costs, the demand for these advanced fluid bags is expected to grow considerably in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Iv Fluid Bags market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Iv Fluid Bags Market Segmental Analysis

Global Intravenous IV Fluid Bags Market is segmented by Capacity, End User, Application, Material and region. Based on Capacity, the market is segmented into < 250 ml, 250 to 500 ml and > 500 ml. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on Application, the market is segmented into Fluid Replacement, Medication Administration and Blood Transfusion. Based on Material, the market is segmented into PVC and Non-PVC. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intravenous Iv Fluid Bags Market

The global intravenous (IV) fluid bags market is significantly driven by the increasing aging population, which contributes to a rise in various health conditions necessitating advanced treatment methodologies. As individuals age, they often experience a higher prevalence of chronic illnesses that require prompt and efficient medication delivery systems. Intravenous administration is favored over oral methods due to its rapid and precise outcomes, leading to greater patient satisfaction and improved health results. Furthermore, heightened awareness among consumers regarding the benefits of IV fluid administration is anticipated to bolster market growth throughout the forecast period, underscoring the vital role these products play in modern healthcare provision.

Restraints in the Global Intravenous Iv Fluid Bags Market

The Global Intravenous IV Fluid Bags market faces significant restraints due to several pressing concerns. Authorities are increasingly apprehensive about the risk of infections and vein collapse associated with prolonged use of needles, which could adversely affect market growth. Additionally, the potential for nutrient imbalances resulting from suboptimal monitoring of intravenous therapies presents another challenge. Furthermore, alternative solutions such as plastic and glass bottles, as well as infusion pumps, offer competition to traditional IV fluid bags, potentially diminishing demand. Moreover, standard 1-liter IV bags pose risks when used in pediatric care, as children should not be exposed to such large volumes of electrolyte solutions.

Market Trends of the Global Intravenous Iv Fluid Bags Market

The Global Intravenous IV Fluid Bags market is witnessing a robust growth trend driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, particularly among the aging population. Additionally, an increase in gastrointestinal disorders is propelling demand for IV fluid bags. However, concerns over the environmental impact and health risks associated with PVC-based medical fluid bags may pose challenges to market expansion. Despite these hurdles, the global expansion of healthcare facilities and an increased focus on patient care is significantly enhancing the adoption of intravenous fluid bags, ensuring continual market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Intravenous IV Fluid Bags Market Size by Capacity & CAGR (2025-2032)

• Market Overview
• < 250 ml
• 250 to 500 ml
• 500 ml

Global Intravenous IV Fluid Bags Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centres
• Homecare Settings

Global Intravenous IV Fluid Bags Market Size by Application & CAGR (2025-2032)

• Market Overview
• Fluid Replacement
• Medication Administration
• Blood Transfusion

Global Intravenous IV Fluid Bags Market Size by Material & CAGR (2025-2032)

• Market Overview
• PVC
• Non-PVC

Global Intravenous IV Fluid Bags Market Size & CAGR (2025-2032)

• North America (Capacity, End User, Application, Material)
  • US
  • Canada
• Europe (Capacity, End User, Application, Material)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Capacity, End User, Application, Material)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Capacity, End User, Application, Material)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Capacity, End User, Application, Material)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Life Science Corp. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amcor plc (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Technoflex (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sippex (Germany) (A MEDIPPEX Co.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polycine GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemotronic S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedicoPack A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kraton Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PolyCine GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fosmo Med (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations